Cardiol Therapeutics Inc.
CRDL.TO
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.79% | -20.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.54% | -17.70% | |||
| Operating Income | 5.54% | 17.70% | |||
| Income Before Tax | -4.56% | 1.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.56% | 1.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.56% | 1.16% | |||
| EBIT | 5.54% | 17.70% | |||
| EBITDA | 5.55% | 17.52% | |||
| EPS Basic | -4.58% | 3.85% | |||
| Normalized Basic EPS | -4.58% | 3.74% | |||
| EPS Diluted | -4.58% | 3.85% | |||
| Normalized Diluted EPS | -4.58% | 3.74% | |||
| Average Basic Shares Outstanding | 0.05% | 2.74% | |||
| Average Diluted Shares Outstanding | 0.05% | 2.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||